National Institutes of Health (NIH)

Data from Phase 3 clinical trial confirm vaccine is effective.

The Phase 2/3 clinical trial will evaluate experimental antibodies BRII-196 and BRII-198. 

Using a recently developed DNA base-editing technique, researchers correct accelerating aging disorder.

Scientists regenerate parts of the skull affected by craniosynostosis, a common birth defect.

NIH-supported pilot study found team-based approach may improve buprenorphine care.

The women were part of a larger group trying to conceive after one or two prior miscarriages.

DNA-based “liquid biopsy” could help save lives and reduce health disparities.

Bacteria commonly cause human gastroenteritis, inflammation of the lining of the intestines.

Therapy may be a promising addition to current approaches to treatment.

Taurine, which helps the body digest fats and oils, could offer treatment benefit.